Nymox Pharmaceutical Corp (NASDAQ:NYMX)

CAPS Rating: 1 out of 5

A biopharmaceutical company with three proprietary products on the market and a R&D of drug & diagnostic products in development for the treatment of enlarged prostate, Alzheimer's disease contamination of food and drink products and bacterial infections.

Recs

0
Player Avatar pchop123 (79.61) Submitted: 12/4/2012 10:17:31 AM : Underperform Start Price: $7.10 NYMX Score: +4.54

what's to like going forward for several months anyway???

Featured Broker Partners


Advertisement